"Exelixis hopes to hear good news soon from the European Committee for Medicinal Products for Human Use, or CHMP. The company has been working with its partner, Sobi, to prepare for a possible European approval."
Does anyone have a feel for when this committe meets and when it publicizes it's decisions? Furthermore, will this have a meaningful impact on share price? I know they hired Sobi quite a while ago, so one would hopw that they should be ready to roll and deliver products as soon as the committee acts.
Answering my own question (from the EMA web sight) I have found that the CHMP meeting will be Nov. 18-21 and although agendas and minutes are not made public, decisions are released shortly after the meeting, but no timetable has been released.
The CHMP will meet twice more this year....11/18/13 thru 11/21/13 & 12/16/13 thru 12/21/13.
They don't publish their meeting agenda, but will post highlights in the wake of each meeting.
I wouldn't expect a significant impact on SP, as the NPU has been in place since the deal was first announced with SOBI. I think European approval in MTC will be largely a non-event.